Proteinuria is common in the adult population and its clinical significance can vary widely. A clear diagnostic process is needed to identify the cause of the findings and guide the treatment ...

Proteinuria is an abnormal concentration of protein in the urine and it may result from various causes, depending on the specific circumstances. The kidneys continuously filter the blood to excrete ...

Q: Proteinuria: I am 47 years old and began running about 7 years ago. I run 2 - 5 miles 3 or 4 days a week. Almost immediately after starting running 7 years ago, my MD told me I had developed a very ...

What further evaluation is needed for an asymptomatic patient whose urinalysis reveals the presence of calcium oxalate crystals and/or protein? —Nick Shah, MD, Dunnellon, Fla. Calcium oxalate crystals ...

Study findings suggest targeted inhibition of APOL1 function can reduce proteinuria. Inaxaplin is an investigational selective small-molecule inhibitor of APOL1 ion channel function, Ogo Egbuna, MD, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The association between 24-hour collection and urine ...

February 16, 2010 — Proteinuria may help predict outcomes in chronic kidney disease (CKD) independent of estimated glomerular filtration rate (eGFR) level, according to the results of a ...

Culture and Sensitivity Nondihydropyridine calcium channel blockers (non-DHP CCBs) appear to reduce proteinuria in patients with diabetic kidney disease Nondihydropyridine calcium channel blockers ...

LONG BEACH, Calif. -- Iptacopan (Fabhalta) was safe and effective for reducing proteinuria in biopsy-confirmed immunoglobulin A nephropathy (IgAN), according to interim findings from the phase III ...

(Upper panel) Normal podocytes: Ephrin-B1 at slit diaphragm interacts with nephrin via the extracellular site and with Par6 via the cytoplasmic site. (Lower panel) Podocytes stimulated by anti-nephrin ...

A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing VISIONARY study. In the first 320 trial participants randomized in the phase ...